A

20/20 Biolabs Inc
D

AIDX

0.30510
USD
-0.06
(-16.71%)
مغلق
حجم التداول
2,269
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
3,896,219

العنوان: 20/20 Biolabs Inc

القطاع: الرعاية الصحية
الصناعة: Medical Devices
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity thatconsists of inflammatory biomarkers.